Corporate News 24-Nov-23
Gland Pharma's Pashamylaram unit clears USFDA inspection
Gland Pharma has received Establishment Inspection Report (EIR) from the US FDA indicating closure of the inspection of its Pashamylaram facility in Hyderabad.
Previous News
Gland Pharma
( Results - Analysis 15-Feb-24 11:08 )
Gland Pharma allots 2,400 equity shares under ESOS
( Corporate News - 26-Mar-24 09:55 )
Gland Pharma Ltd soars 0.86%, gains for fifth straight session
( Hot Pursuit - 09-Jun-23 13:00 )
Gland Pharma Ltd slips for fifth straight session
( Hot Pursuit - 25-May-22 13:35 )
Gland Pharma Ltd soars 1.64%, Gains for third straight session
( Hot Pursuit - 20-Apr-22 13:05 )
Gland Pharma to hold board meeting
( Corporate News - 01-Jan-21 10:49 )
Gland Pharma receives USFDA approval for Cetrorelix Acetate for Injection
( Corporate News - 29-Apr-24 10:49 )
Gland Pharma rises post conclusion of US FDA's GMP inspection at Dundigal facility
( Hot Pursuit - 14-Jul-23 12:26 )
Gland Pharma Ltd gains for third straight session
( Hot Pursuit - 20-Dec-23 13:05 )
Gland Pharma
( Results - Analysis 23-May-24 10:29 )
Shares of Gland Pharma debut on bourses
( Corporate News - 20-Nov-20 09:03 )
Other Stories
Gujarat Toolroom to conduct EGM
08-Jul-24 19:53
Macro Intl. to conduct AGM
08-Jul-24 19:52
Ecoboard Industries schedules AGM
08-Jul-24 19:52
Eraaya Lifespaces schedules EGM
08-Jul-24 19:52
Binny to convene EGM
08-Jul-24 19:52
ICRA upgrades long term rating on bank facilities of Keystone Realtors
08-Jul-24 19:17
Sadbhav Engineering schedules EGM
08-Jul-24 19:08
Board of Va Tech Wabag approves divestment of Wabag Romania
08-Jul-24 19:08
Global Capital Markets to announce Quarterly Result
08-Jul-24 19:07
Motherson Sumi Wiring India schedules board meeting
08-Jul-24 19:07
Back
Top
